WHO Expands Device Prequalification to Condoms, IUDs

The World Health Organization's Prequalification of Medical Devices programme launched a significant expansion on 25 September 2026, adding male and female condoms, copper-bearing IUDs, and AI-based TB screening software to its list of eligible categories — and, in the same move, absorbing contraceptive-device review that had run separately under UNFPA. For manufacturers selling into UN procurement channels, the headline is not the launch date. It is the deadlines now attached to it.

Why a UN agency's device list matters to RA/QA

WHO prequalification is not a marketing authorization — WHO is explicit that listing is not an approval, which remains the prerogative of national regulators. What it is, is a procurement gate: UN agencies, the Global Fund, and a large share of low- and middle-income country tenders require WHO prequalification or an equivalent stringent-regulatory-authority pathway as a condition of eligibility to bid. A condom, IUD, or TB-screening software product can hold every national approval it needs and still be shut out of that procurement channel without a current WHO acknowledgment. Folding contraceptive devices into WHO's own programme, rather than leaving them under UNFPA's separate process, centralizes that gate under one procedure and one deadline calendar — which is exactly why the transition dates matter more than the announcement itself.

The deadlines, in order

• 1 October 2026 — WHO assessment opens for products already listed with UNFPA, plus CAD-TB software and male circumcision devices.
• 1 April 2027 — WHO assessment opens for contraceptive devices that were never submitted to UNFPA at all.
• 30 September 2028 — the deadline for manufacturers holding a UNFPA-era acknowledgment to file a new WHO application; miss it, and WHO may remove the product from its acknowledgment list.
• 30 September 2030 — the outer date through which WHO says it will otherwise continue recognizing UNFPA-era acknowledgments.

The software category is the one to watch

CAD-TB — computer-aided detection software that reads chest X-rays for tuberculosis screening — is a software-as-a-medical-device category entering a procurement-linked prequalification pathway built originally for physical devices and diagnostics. Sponsors with AI-based screening or triage tools should not assume the eligibility windows and the underlying PQDx_464 procedure map cleanly onto a software product's lifecycle (version updates, model retraining, post-market changes) the way they do for a fixed hardware device; that is the open operational question for this category as the pathway runs in practice, not a settled one WHO's launch materials answer directly.

Frequently asked questions

What did WHO announce on 25 September 2026?

An expansion of its Prequalification of Medical Devices programme to three new eligible categories: male and female condoms, copper-bearing intrauterine devices (IUDs), and computer-aided-detection software for tuberculosis screening (CAD-TB). Condom and IUD prequalification moves from UNFPA, which had run it separately, into WHO's own device programme alongside WHO's existing male circumcision device and in vitro diagnostic tracks.

What are the key dates?

Products previously submitted to UNFPA, plus CAD-TB software and male circumcision devices, became eligible for WHO assessment from 1 October 2026. Contraceptive devices never submitted to UNFPA become eligible from 1 April 2027. Manufacturers with UNFPA-listed contraceptives must file a new WHO application by 30 September 2028, or WHO may drop the product from its acknowledgment list; UNFPA-era acknowledgments are otherwise recognized through 30 September 2030.

Why does WHO prequalification matter commercially?

WHO prequalification underpins eligibility for procurement by UN agencies, the Global Fund, and many low- and middle-income country tenders. A product that loses its acknowledgment for lack of a timely refiling can lose access to those procurement channels, independent of whatever national marketing authorization it already holds.

Is there a fee for refiling?

WHO says it will waive the WHO assessment fee for products whose UNFPA assessment fee was already paid in full. The new procedure governing all of this, PQDx_464, supersedes the prior male circumcision device procedure and the UNFPA-era contraceptive guidance.